...
首页> 外文期刊>Molecular Immunology >Epitope-based immunoinformatics study of a novel Hla-MntC-SACOL0723 fusion protein from Staphylococcus aureus: Induction of multi-pattern immune responses
【24h】

Epitope-based immunoinformatics study of a novel Hla-MntC-SACOL0723 fusion protein from Staphylococcus aureus: Induction of multi-pattern immune responses

机译:基于表位的HLA-MNTC-SACOL0723融合蛋白来自金黄色葡萄球菌的展位免疫信息研究:诱导多模式免疫应答

获取原文
获取原文并翻译 | 示例
           

摘要

Staphylococcus aureus infections are now one of the most common causes of surgical drainage, bacteremia, and hospital-acquired infections. The emergence of antibiotic resistance has increased mortality and costs of treatment. The design of a new vaccine against S. aureus would have a great beneficial impact on public health. In the current report, we design and introduce a novel epitope-based fusion protein (Hla, MntC and SACOL0723) and investigate its biological activities. Three known antigenic proteins from S. aureus were analyzed for the prediction of immunogenic B and T-cell epitopes and validated using bioinformatics tools. The affinity and the map of interactions between the receptor and ligand were evaluated via docking protocols. Functional activity of the recombinant protein was assessed by western blot and opsonophagocytosis tests and determining the bacterial burden from the infected tissues. To determine the type of induced immunity, cytokines profile and isotyping ELISA was performed. Based on in silico analysis, seven epitopes rich domain including highly scored T and B-cell epitopes were selected. The study results indicated that the high titer of specific antibodies raised against the vaccine candidate could opsonize the bacteria and decrease the viable bacterial cells. The fusion protein was able to elicit a mixture of Th1, Th2, and Th17 immune responses more towards Th1 and Th17. In conclusion, the fusion protein formulated with alum could be considered as a potential vaccine candidate for protection against S. aureus in the near future.
机译:金黄色葡萄球菌感染现在是手术引流,菌血症和医院收养的感染最常见的原因之一。抗生素抗性的出现增加了死亡率和治疗费用。针对S.金黄色葡萄球菌的新疫苗对公共卫生有很大的有益影响。在当前报告中,我们设计并引入新的表位融合蛋白(HLA,MNTC和Sacol0723),并研究其生物学活性。分析来自S.UUREUS的三种已知的抗原蛋白,用于预测免疫原性B和T细胞表位并使用生物信息学工具进行验证。通过对接方案评估受体和配体之间的相互作用的亲和力和图谱。通过Western印迹和Opsonococococytosis试验评估重组蛋白的功能活性,并确定来自受感染组织的细菌负担。为了确定诱导的免疫,进行细胞因子曲线和同种型ELISA。基于Silico分析,选择了七种富表域富域,包括高分得分和B细胞表位。研究结果表明,针对疫苗候选的特异性抗体的高滴度可以调查细菌并降低活细菌细胞。融合蛋白能够引发Th1,Th2和Th17的混合物,朝向Th1和Th17更高。总之,用明矾配制的融合蛋白可以被认为是在不久的将来保护针对金黄色葡萄球菌的潜在疫苗候选者。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号